If you’re a DCT platform founder, investor, or agency wanting to support this growing market, you won’t want to miss this conversation with the person who knows more about setting up and managing DCTs than virtually anyone on the planet. Today’s guest is Laura Podolsky, Esq., founding General Counsel of Science37, a startup with a valuation of $1.05B when it went public in Spring 2021. Laura currently serves some of Nixon Gwilt Law’s top Life Sciences and Healthcare Innovation clients.
Show Notes
If you’re a DCT platform founder, investor, or agency wanting to support this growing market, you won’t want to miss this conversation with the person who knows more about setting up and managing DCTs than virtually anyone on the planet. Today’s guest is Laura Podolsky, Esq., founding General Counsel of Science37, a startup with a valuation of $1.05B when it went public in Spring 2021. Laura currently serves some of Nixon Gwilt Law’s top Life Sciences and Healthcare Innovation clients.
***Bonus: Download Laura’s Top 5 Friction Points for DCT Providers in the Recommended Resources section below
What you’ll get out of this episode
- Why Decentralized Clinical Trials (DCT) got a boost from the pandemic—and whether this boost is likely to continue
- What benefits and drawbacks exist with DCT when compared to traditional clinical trials
- How companies which support DCTs can gain access to these trials via the platforms (think: mobile nursing agencies, patient recruitment companies, and mobile labs)
- What special privacy considerations are needed in DCT and how companies can adjust their processes to meet those needs
- What investors and sponsors look for in a DCT platform during due diligence (including a handy resource)
Quotables
Recommended Resources
Join the Conversation
Are you a digital health or health system innovator? Tell us what topics and people you’d like us to cover in future episodes:
Follow our daily updates on LinkedIn:
About Your Hosts
Carrie Nixon and Rebecca Gwilt are partners at Nixon Gwilt Law, a healthcare innovation law firm exclusively serving Providers, Digital Health Companies, and Life Science Businesses seeking to transform the way we receive and experience healthcare. Find out more at NixonGwiltLaw.com.
This podcast is produced by Slice of Healthcare LLC.
What is Decoding Healthcare Innovation?
New episodes every other Wednesday. Co-hosted by Carrie Nixon, Esq. & Rebecca E. Gwilt, Esq. Key topics center around healthcare law, policy, innovation, startups & digital health.
Carrie Nixon and Rebecca Gwilt are partners at Nixon Gwilt Law, a healthcare innovation law firm exclusively serving Providers, Digital Health Companies, and Life Science Businesses seeking to transform the way we receive and experience healthcare. Find out more at NixonGwiltLaw.com.